ENSG00000072506


Homo sapiens

Features
Gene ID: ENSG00000072506
  
Biological name :HSD17B10
  
Synonyms : HSD17B10 / hydroxysteroid 17-beta dehydrogenase 10 / Q99714
  
Possible biological names infered from orthology :
  
Species: Homo sapiens
  
Chr. number: X
Strand: -1
Band: p11.22
Gene start: 53431258
Gene end: 53434373
  
Corresponding Affymetrix probe sets: 202282_at (Human Genome U133 Plus 2.0 Array)   
  
Cross references: Ensembl peptide - ENSP00000364453
Ensembl peptide - ENSP00000168216
Ensembl peptide - ENSP00000364447
NCBI entrez gene - 3028     See in Manteia.
OMIM - 300256
RefSeq - NM_001037811
RefSeq - NM_004493
RefSeq Peptide - NP_001032900
RefSeq Peptide - NP_004484
swissprot - Q99714
swissprot - Q5H928
swissprot - A0A0S2Z410
Ensembl - ENSG00000072506
  
Related genetic diseases (OMIM): 300438 - HSD10 mitochondrial disease, 300438
See expression report in BioGPS
See gene description in Wikigenes
See gene description in GeneCards
See co-cited genes in PubMed


Ortholog prediction (from Ensembl)
Ortholog nameID Species
 hsd17b10ENSDARG00000017781Danio rerio
 Hsd17b10ENSMUSG00000025260Mus musculus


Paralog prediction (from Ensembl)
Paralog nameIDSimilarity(%)
Q9BPX1 / HSD17B14 / hydroxysteroid 17-beta dehydrogenase 14ENSG0000008707630
Q92506 / HSD17B8 / hydroxysteroid 17-beta dehydrogenase 8ENSG0000020422830
HPGD / P15428 / 15-hydroxyprostaglandin dehydrogenaseENSG0000016412028
DHRS4 / Q9BTZ2 / dehydrogenase/reductase 4ENSG0000015732627
CBR4 / Q8N4T8 / carbonyl reductase 4ENSG0000014543926
BDH2 / Q9BUT1 / 3-hydroxybutyrate dehydrogenase 2ENSG0000016403924
DHRS2 / Q13268 / dehydrogenase/reductase 2ENSG0000010086724
Q6PKH6 / DHRS4L2 / dehydrogenase/reductase 4 like 2ENSG0000018763022
DCXR / Q7Z4W1 / dicarbonyl and L-xylulose reductaseENSG0000016973821


Protein motifs (from Interpro)
Interpro ID Name
 IPR002347  Short-chain dehydrogenase/reductase SDR
 IPR020904  Short-chain dehydrogenase/reductase, conserved site
 IPR036291  NAD(P)-binding domain superfamily


Gene Ontology (GO)
TypeGO IDTermEv.Code
 biological_processGO:0006629 lipid metabolic process TAS
 biological_processGO:0007005 mitochondrion organization IMP
 biological_processGO:0008033 tRNA processing IEA
 biological_processGO:0009083 branched-chain amino acid catabolic process TAS
 biological_processGO:0051289 protein homotetramerization IDA
 biological_processGO:0055114 oxidation-reduction process IEA
 biological_processGO:0070901 mitochondrial tRNA methylation TAS
 biological_processGO:0090646 mitochondrial tRNA processing TAS
 biological_processGO:0097745 mitochondrial tRNA 5"-end processing IDA
 biological_processGO:1990180 mitochondrial tRNA 3"-end processing IDA
 cellular_componentGO:0005737 cytoplasm TAS
 cellular_componentGO:0005739 mitochondrion IDA
 cellular_componentGO:0005759 mitochondrial matrix TAS
 cellular_componentGO:0005886 plasma membrane TAS
 cellular_componentGO:0030678 mitochondrial ribonuclease P complex IDA
 molecular_functionGO:0000049 tRNA binding IDA
 molecular_functionGO:0003723 RNA binding HDA
 molecular_functionGO:0003857 3-hydroxyacyl-CoA dehydrogenase activity EXP
 molecular_functionGO:0005515 protein binding IPI
 molecular_functionGO:0008709 cholate 7-alpha-dehydrogenase activity TAS
 molecular_functionGO:0016491 oxidoreductase activity IEA
 molecular_functionGO:0030283 testosterone dehydrogenase [NAD(P)] activity IEA
 molecular_functionGO:0047015 3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity IEA


Pathways (from Reactome)
Pathway description
tRNA processing in the mitochondrion
tRNA modification in the mitochondrion
Branched-chain amino acid catabolism
rRNA processing in the mitochondrion


Phenotype (from MGI, Zfin or HPO)
IDPhenotypeDefinition Genetic BG
 HP:0000407 Hearing loss, sensorineural "Hearing loss caused by damage or dysfunction of the auditory nerve (cranial nerve VIII)." [HPO:curators]
Show

 HP:0000546 Retinal degeneration 
Show

 HP:0000572 Visual loss 
Show

 HP:0000639 Nystagmus "Rhythmic, involuntary oscillations of one or both eyes related to abnormality in fixation, conjugate gaze, or vestibular mechanisms." [HPO:curators]
Show

 HP:0000648 Optic atrophy 
Show

 HP:0000708 Behavioural/Psychiatric Abnormality 
Show

 HP:0000711 Restlessness 
Show

 HP:0000713 Agitation 
Show

 HP:0000718 Aggressive behavior "Aggressive behavior can denote verbal aggression, physical aggression against objects, physical aggression against people, and may also include aggression towards oneself." [HPO:curators]
Show

 HP:0000750 Impaired language development 
Show

 HP:0001249 Mental retardation 
Show

 HP:0001250 Seizures "Seizures are an intermittent `abnormality of the central nervous system` (FMA:HP:0002011) due to a sudden, excessive, disorderly discharge of cerebral neurons and characterized clinically by some combination of disturbance of sensation, loss of consciousness, impairment of psychic function, or convulsive movements." [HPO:probinson]
Show

 HP:0001252 Muscular hypotonia "Muscular hypotonia is an abnormally low muscle tone (the amount of tension or resistance to movement in a muscle), often involving reduced muscle strength. Hypotonia is characterized by a diminished resistance to passive stretching." [HPO:curators]
Show

 HP:0001260 Dysarthria "Dysarthric speech is a general description referring to a neurological speech disorder characterized by poor articulation. Depending on the involved neurological structures, dysarthria may be further classified as spastic, flaccid, ataxic, hyperkinetic and hypokinetic, or mixed." [HPO:curators]
Show

 HP:0001263 Developmental retardation "A delay in the achievement of motor or mental milestones manifested prior to age 18 and generally associated with lifelong mental and/or physical impairments." [HPO:curators]
Show

 HP:0001266 Choreoathetosis 
Show

 HP:0001290 Generalized hypotonia "Generalized muscular hypotonia (abnormally low muscle tone)." [HPO:curators]
Show

 HP:0001423 X-linked dominant inheritance "A mode of inheritance that is observed for dominant traits related to a gene encoded on the X chromosome. In the context of medical genetics, X-linked dominant disorders tend to manifest very severely in affected males. The severity of manifestation in females may depend on the degree of skewed X inactivation." [HPO:curators]
Show

 HP:0001639 Hypertrophic cardiomyopathy 
Show

 HP:0001942 Metabolic acidosis 
Show

 HP:0001943 Hypoglycemia "A lower than normal level of blood glucose." [HPO:curators]
Show

 HP:0002120 Cerebral cortical atrophy 
Show

 HP:0002344 Progressive neurologic deterioration 
Show

 HP:0002376 Developmental regression 
Show

 HP:0002510 Spastic tetraplegia "Spastic paralysis affecting all four limbs." [HPO:curators]
Show

 HP:0003128 Lactic acidemia "An abnormal buildup of `lactic acid` (CHEBI:28358) in the body, leading to `acidification` (GO:0045851) of the blood." [HPO:probinson]
Show

 HP:0003593 Early onset 
Show

 HP:0003812 Phenotypic variability 
Show

 HP:0100022 Abnormality of movement "An abnormality of movement with a neurological basis characterized by changes in coordination and speed of voluntary movements." [HPO:probinson]
Show

  


Interacting proteins (from Reactome)
Interactor ID Name Interaction type
 ENSG00000100890 O15091 / KIAA0391  / complex
 ENSG00000072506 Q99714 / HSD17B10 / hydroxysteroid 17-beta dehydrogenase 10  / complex
 ENSG00000174173 Q7L0Y3 / TRMT10C / tRNA methyltransferase 10C, mitochondrial RNase P subunit  / complex






 

1 s.

 
External programs and data are copyrighted by and are the property of their respective authors.
The Manteia system, data and analyses are provided "as is" with no warranties, expressed or implied as to capabilities or accuracy. User assumes the entire risk as to the results and performance of the software, data and documentation


                   


© Olivier Tassy / Olivier Pourquie 2007-2024
contact: otassy@igbmc.fr